TD-8954
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TD-8954, covering 2017-06-14 to 2017-08-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects [Phase 1]